4D-QSAR Study of 17β-Hydroxysteroid Dehydrogenase Type 3 Inhibitors

被引:1
作者
Martins, Jodo Paulo A. [1 ]
de Melo, Eduardo B. [2 ]
机构
[1] Univ Fed Minas Gerais, Dept Quim, BR-31270901 Belo Horizonte, MG, Brazil
[2] Univ Estadual Oeste Parana, Lab Quim Med & Ambiental TeOr, BR-85819110 Cascavel, PR, Brazil
关键词
prostate cancer; 17; beta-HSD3; computer-aided drug design; Web-4D-QSAR; DIFFERENT VALIDATION CRITERIA; REAL EXTERNAL PREDICTIVITY; PROSTATE-CANCER; QSAR MODELS; MULTIDIMENSIONAL QSAR; LQTA-QSAR; REGRESSION; QSPR; DISCOVERY; SELECTION;
D O I
10.21577/0103-5053.20190052
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Prostate cancer is one of the most common form of cancer among men, and its incidence has been increasing progressively. Since the prostate depends on androgenic hormones to regulate its growth and development, interference with androgenic biosynthesis are important to control the disease. Thus, in this work, a 4D-quantitative structure-activity relationship (QSAR) receptor independent study was carried out using the Laboratorio de Quimiometria Teorica e Aplicada (LQTA)-QSAR approach and the new tool Web-4D-QSAR with a set of benzylidene oxazolidinedione and thiazolidinedione inhibitor of the 17 beta-hydroxysteroid dehydrogenase type 3. The obtained model is robust, free from chance correlation, and with good predictability in all tests performed. In addition to this result, a good mecanistic interpretation related to the binding with the biological target could be traced, which strengthens its potential application in virtual screening and design of new inhibitors of the studied enzyme with the possibility of use in the pharmacological treatment of prostate cancer.
引用
收藏
页码:1548 / 1557
页数:10
相关论文
共 50 条
[21]   Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3 [J].
Djigoue, Guy Bertrand ;
Kenmogne, Lucie Carolle ;
Roy, Jenny ;
Maltais, Rene ;
Poirier, Donald .
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (17) :5433-5451
[22]   Web-4D-QSAR: A web-based application to generate 4D-QSAR descriptors [J].
Ataide Martins, Joao Paulo ;
Rougeth de Oliveira, Marco Antonio ;
Oliveira de Queiroz, Mario Sergio .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2018, 39 (15) :917-924
[23]   Molecular Modeling Studies of 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors through Receptor-Based 3D-QSAR and Molecular Dynamics Simulations [J].
Qian, Haiyan ;
Chen, Jiongjiong ;
Pan, Youlu ;
Chen, Jianzhong .
MOLECULES, 2016, 21 (09)
[24]   4D-QSAR studies of CB2 cannabinoid receptor inverse agonists: a comparison to 3D-QSAR [J].
Zhang, Houpan ;
Lv, Qiaoli ;
Xu, Weidong ;
Lai, Xiaoping ;
Liu, Ya ;
Tu, Guogang .
MEDICINAL CHEMISTRY RESEARCH, 2019, 28 (04) :498-504
[25]   Molecular dynamics-guided receptor-dependent 4D-QSAR studies of HDACs inhibitors [J].
Hu, Zhihao ;
Lin, Qianxia ;
Liu, Haiyun ;
Zhao, Tiansheng ;
Yang, Bowen ;
Tu, Guogang .
MOLECULAR DIVERSITY, 2022, 26 (02) :757-768
[26]   Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk [J].
Karageorgi, Stalo ;
McGrath, Monica ;
Lee, I-Min ;
Buring, Julie ;
Kraft, Peter ;
De Vivo, Immaculata .
GYNECOLOGIC ONCOLOGY, 2011, 121 (01) :54-58
[27]   Light-switchable diazocines as potential inhibitors of testosterone-synthesizing 17β-hydroxysteroid dehydrogenase 3 [J].
Wages, F. ;
Brandt, T. ;
Martin, H. J. ;
Herges, R. ;
Maser, E. .
CHEMICO-BIOLOGICAL INTERACTIONS, 2024, 390
[28]   Synthesis of a dansyl-labeled inhibitor of 17β-hydroxysteroid dehydrogenase type 3 for optical imaging [J].
Kenmogne, Lucie Carolle ;
Maltais, Rene ;
Poirier, Donald .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (09) :2179-2183
[29]   Phenylbenzenesulfonates and -sulfonamides as 17β-hydroxysteroid dehydrogenase type 2 inhibitors: Synthesis and SAR-analysis [J].
Vuorinen, Anna ;
Engeli, Roger T. ;
Leugger, Susanne ;
Kreutz, Christoph R. ;
Schuster, Daniela ;
Odermatt, Alex ;
Matuszczak, Barbara .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (13) :2982-2985
[30]   Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) [J].
Adeniji, Adegoke O. ;
Twenter, Barry M. ;
Byrns, Michael C. ;
Jin, Yi ;
Winkler, Jeffrey D. ;
Penning, Trevor M. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) :1464-1468